CLVS - Clovis Oncology Inc. (CLVS) CEO Patrick Mahaffy on Q1 2022 Results - Earnings Call Transcript

Clovis Oncology, Inc. (CLVS) Q1 2022 Earnings Conference Call May 4, 2022, 08:30 AM ET Company Participants Anna Sussman - VP, IR and Corporate Communications Patrick Mahaffy - President and CEO Thomas Harding - Chief Scientific Officer Dan Muehl - CFO Conference Call Participants Charlie Ferranti - Goldman Sachs Presentation Operator Good morning. And welcome to the Clovis Oncology First Quarter 2022 Operating Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions]. I will now like to turn the call over to Anna Sussman, Vice President of Investor Relations and Corporate Communications for Clovis. Please go ahead. Anna Sussman Thank you. Good morning, everyone. Welcome to the Clovis Oncology first quarter 2022 conference call. Thank you for joining us. You've likely seen this morning's news release and if not, it's available on

For further details see:

Clovis Oncology, Inc. (CLVS) CEO Patrick Mahaffy on Q1 2022 Results - Earnings Call Transcript